Literature DB >> 8651556

Surgical palliation for ductal adenocarcinoma of the pancreas.

D J Deziel1, B Wilhelmi, E D Staren, A Doolas.   

Abstract

The short and long term outcomes of operative palliation for unresected ductal adenocarcinoma were evaluated in a critical review of 319 patients from 1972-1990. A total of 154 of 243 operated patients had palliative procedures, including biliary drainage in 86 per cent and combined biliary drainage and gastrojejunostomy in 53 per cent. Overall mortality rate was 13 per cent; one-half of the patients had some complication during their remaining lifetime. Biliary enteric anastomoses provided clinical relief of jaundice in 78 per cent of patients at hospital discharge; jaundice recurred in 16.7 per cent. The overall outcomes of choledochojejunostomy, cholecystojejunostomy, and choledochoduodenostomy were similar and superior to biliary intubation. Choledochojejunostomy was associated with a trend toward longer survival. Gastrojejunostomy did not affect overall results. However, upper gastrointestinal hemorrhage was more frequent when gastrojejunostomy was added to biliary bypass. Late duodenal obstruction developed in 6 per cent of patients initially treated by biliary drainage alone. Mean survival was 8.1 months; one-year survival was 18.2 per cent. Operative palliation for ductal cancer of the pancreas has important morbidity and mortality. Biliary enteric anastomoses provide lifelong relief of jaundice for most patients. Selective, rather than routine, gastrojejunostomy is recommended.

Entities:  

Mesh:

Year:  1996        PMID: 8651556

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  6 in total

1.  Surgical palliation for pancreatic malignancy: practice patterns and predictors of morbidity and mortality.

Authors:  Edmund K Bartlett; Heather Wachtel; Douglas L Fraker; Charles M Vollmer; Jeffrey A Drebin; Rachel R Kelz; Giorgos C Karakousis; Robert E Roses
Journal:  J Gastrointest Surg       Date:  2014-03-27       Impact factor: 3.452

Review 2.  Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials.

Authors:  A Schwarz; H G Beger
Journal:  Int J Pancreatol       Date:  2000-02

3.  Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma.

Authors:  Edwina N Scott; Giuseppe Garcea; Helena Doucas; Will P Steward; Ashley R Dennison; David P Berry
Journal:  HPB (Oxford)       Date:  2009-03       Impact factor: 3.647

Review 4.  Pancreatic cancer.

Authors:  S J Cohen; W H Pinover; J C Watson; N J Meropol
Journal:  Curr Treat Options Oncol       Date:  2000-12

5.  Hepaticocholecystoduodenostomy compared with Roux-en-y choledochojejunostomy for decompression of the biliary tract.

Authors:  Omar Shah; Parveen Shah; Showkat Zargar
Journal:  Ann Saudi Med       Date:  2009 Sep-Oct       Impact factor: 1.526

6.  Palliative interventional and surgical therapy for unresectable pancreatic cancer.

Authors:  Volker Assfalg; Norbert Hüser; Christoph Michalski; Sonja Gillen; Jorg Kleeff; Helmut Friess
Journal:  Cancers (Basel)       Date:  2011-02-14       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.